A diagnostic algorithm for patients with Glanzmann’s thrombasthenia
This example algorithm was developed by Novo Nordisk in collaboration with experts and follows the latest treatment guidelines. It is meant to raise awareness of common steps for assessing patients and diagnosing Glanzmann’s thrombasthenia in the emergency department (ED) setting.a
A diagnostic algorithm for patients with Glanzmann’s thrombasthenia
This example algorithm was developed by Novo Nordisk in collaboration with experts and follows the latest treatment guidelines. It is meant to raise awareness of common steps for assessing patients and diagnosing Glanzmann’s thrombasthenia in the emergency department (ED) setting.a
aThe provided example is for discussion purposes only and is not intended to represent a recommended algorithm for actual decision making. This example is for illustrative purposes and does not constitute guidance for medical advice or treatment.
Learn about a potential treatment option for your patients with Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.
Learn about a potential treatment option for your patients with Glanzmann’s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets.